Table 1.
Cmpd | Helical Peptide | Linker | Transition-State Analoguea | IC50b |
---|---|---|---|---|
APP transmembrane residues 707–717: | --------Optimized TSA----------- | |||
---Val-Gly-Gly-Val-Val-Ile-Ala-Thr-Val-Ile---- | ----P2 - P1 - P1′- P2′-P3′----- | |||
1 | Boc-Val-Phe-ψ-Phe-Leu-Val-NH2 | 41 ± 4 | ||
2 | Boc-Val-Gly-Aib-Val-Val-Ile-Aib-Phe-Val-Aib-OCH3 | 58 ± 6 | ||
3 | Boc-Val-Gly-Aib-Val-Val-Ile-Aib-Phe-Val-Aib- | - | -Val-Phe-ψ-Phe-Leu-Val-NH2 | 53 ± 1 |
4 | Boc-Val-Gly-Aib-Val-Val-Ile-Aib-Phe-Val-Aib- | -NH(CH2)2CO- | -Val-Phe-ψ-Phe-Leu-Val-NH2 | 12 ± 2 |
5 | Boc-Val-Gly-Aib-Val-Val-Ile-Aib-Phe-Val-Aib- | -NH(CH2)4CO- | -Val-Phe-ψ-Phe-Leu-Val-NH2 | 10 ± 1 |
6 | Boc-Val-Gly-Aib-Val-Val-Ile-Aib-Phe-Val-Aib- | -NH(CH2)8CO- | -Val-Phe-ψ-Phe-Leu-Val-NH2 | 0.80 ± 0.03 |
7 | - | BocNH(CH2)8CO- | -Val-Phe-ψ-Phe-Leu-Val-NH2 | 16 ± 1 |
8 | Boc-Val-Gly-Aib-Val-Val-Ile-Aib-Phe-Val-Aib- | -NH(CH2)8CO- | -Val-Phe - Phe-Leu-Val-NH2 | 18 ± 3 |
9 | Boc-Val-Gly-Aib-DVal-D Val-Ile-Aib-Phe-Val-Aib- | -NH(CH2)8CO- | -Val-Phe-ψ-Phe-Leu-Val-NH2 | 6 ± 2 |
ψ represents hydoxyethylurea replacement of peptide backbone;
concentration that inhibits 50% activity of 1 nM purified γ-secretase